These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20566427)

  • 1. Oral metronomic chemo-hormonal-therapy of metastatic breast cancer with cyclophosphamide and megestrol acetate.
    Licchetta A; Correale P; Migali C; Remondo C; Francini E; Pascucci A; Magliocca A; Guarnieri A; Savelli V; Piccolomini A; Carli AF; Francini G
    J Chemother; 2010 Jun; 22(3):201-4. PubMed ID: 20566427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
    Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
    BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of treatment related death and febrile neutropaenia with first line palliative chemotherapy for de novo metastatic breast cancer in clinical practice in a middle resource country.
    Phua CE; Tang WH; Yusof MM; Saad M; Alip A; See MH; Taib NA
    Asian Pac J Cancer Prev; 2014; 15(23):10263-6. PubMed ID: 25556458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An exploratory study of sunitinib plus paclitaxel as first-line treatment for patients with advanced breast cancer.
    Kozloff M; Chuang E; Starr A; Gowland PA; Cataruozolo PE; Collier M; Verkh L; Huang X; Kern KA; Miller K
    Ann Oncol; 2010 Jul; 21(7):1436-1441. PubMed ID: 20032126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in older metastatic breast cancer patients.
    Kurtz JE; Rousseau F; Meyer N; Delozier T; Serin D; Nabet M; Djafari L; Dufour P
    Oncology; 2007; 73(3-4):210-4. PubMed ID: 18424884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of metronomic chemotherapy as salvage therapy for patients with metastatic breast cancer.
    Salem DA; Gado NM; Abdelaziz NN; Essa AE; Abdelhafeez ZM; Kamel TH
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):134-40. PubMed ID: 20029469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma.
    Gebbia V; Boussen H; Valerio MR
    Anticancer Res; 2012 Feb; 32(2):529-36. PubMed ID: 22287742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronomic vinorelbine plus bevacizumab as salvage therapy for patients with metastatic breast cancer.
    Saloustros E; Kalbakis K; Vardakis N; Kalykaki A; Milaki G; Rovithi M; Agelaki S; Saridaki Z; Georgoulias V; Mavroudis D
    J BUON; 2011; 16(2):215-8. PubMed ID: 21766488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase II trial.
    Schmid P; Krocker J; Kreienberg R; Klare P; Kittel K; Sommer H; Heinrich G; Steck T; Lichtenegger W; Elling D; Kümmel S
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):401-6. PubMed ID: 19104816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label use of oxaliplatin in patients with metastatic breast cancer.
    Delpeuch A; Leveque D; Rob L; Bergerat JP
    Anticancer Res; 2011 May; 31(5):1765-7. PubMed ID: 21617237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy and concomitant irradiation in inflammatory breast cancer.
    Tubiana-Mathieu N; Lejeune C; Bonnier P; Genet D; Adjadj DJ; Berda JF; Muracciole X; Delaby F; Clavere P; Benyoub A; Rhein B; Juin B; Piana L
    Anticancer Res; 2001; 21(4B):3061-7. PubMed ID: 11712811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: a phase II study in patients with HER2-negative metastatic breast cancer.
    Yoshimoto M; Takao S; Hirata M; Okamoto Y; Yamashita S; Kawaguchi Y; Takami M; Furusawa H; Morita S; Abe C; Sakamoto J
    Cancer Chemother Pharmacol; 2012 Aug; 70(2):331-8. PubMed ID: 22526409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up.
    Genet D; Lejeune C; Bonnier P; Aubard Y; Venat-Bouvet L; Adjadj DJ; Martin J; Labourey JL; Benyoub A; Clavère P; Lebrun-Ly V; Juin P; Piana L; Tubiana-Mathieu N
    Br J Cancer; 2007 Oct; 97(7):883-7. PubMed ID: 17876327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].
    Zhang P; Xu BH; Ma F; Li Q; Yuan P; Wang JY; Zhang P
    Zhonghua Zhong Liu Za Zhi; 2011 May; 33(5):381-4. PubMed ID: 21875471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Response evaluation with mammography and ultrasound].
    Junkermann H; Schmid H; Sinn HP; Wallwiener D
    Zentralbl Gynakol; 1996; 118(10):572-3. PubMed ID: 8999712
    [No Abstract]   [Full Text] [Related]  

  • 18. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral idarubicin and cyclophosphamide for metastatic breast cancer in elderly patients.
    Zaniboni A; Bolognesi A; Arnoldi E; Tabiadon D; Barni S; Intini C
    Anticancer Drugs; 1998 Apr; 9(4):295-9. PubMed ID: 9635918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin and cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil as adjuvant chemotherapy in breast cancer.
    Livi L; Saieva C; Borghesi S; De Luca Cardillo C; Scotti V; Mangoni M; Greto D; Cataliotti L; Paiar F; Bianchi S; Biti GP
    J Chemother; 2009 Nov; 21(5):558-65. PubMed ID: 19933048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.